Sun et al. found that the positive rates of COX-2 by immunohistochemistry in superficial gastritis, gastric atrophy, intestinal metaplasia, dysplasia, and cancer were 10.0%, 35.7%, 37.8%, 41.7%, and 69.5%, respectively [11]. The gene discussed is PTGS2; the disease is chronic atrophic gastritis.